163 related articles for article (PubMed ID: 21691785)
1. Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide.
Kabir ME; Karim N; Krishnaswamy S; Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Dec; 92(6):1151-60. PubMed ID: 21691785
[TBL] [Abstract][Full Text] [Related]
2. An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Apr; 90(2):553-64. PubMed ID: 21305279
[TBL] [Abstract][Full Text] [Related]
3. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution.
Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
Anal Biochem; 2009 Dec; 395(1):16-24. PubMed ID: 19665444
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.
Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Antimicrob Agents Chemother; 2006 Sep; 50(9):3090-7. PubMed ID: 16940106
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies.
Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
J Antibiot (Tokyo); 2006 Feb; 59(2):73-9. PubMed ID: 16629406
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of recombinant single chain fragment variable anti-idiotypic antibody specific to Aspergillus fumigatus membrane protein.
Krishnaswamy S; Kabir ME; Rahman MM; Miyamoto M; Furuichi Y; Komiyama T
J Immunol Methods; 2011 Mar; 366(1-2):60-8. PubMed ID: 21277307
[TBL] [Abstract][Full Text] [Related]
7. Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies.
Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
J Biochem; 2010 May; 147(5):723-33. PubMed ID: 20097900
[TBL] [Abstract][Full Text] [Related]
8. An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
BMC Biotechnol; 2009 Dec; 9():99. PubMed ID: 20003392
[TBL] [Abstract][Full Text] [Related]
9. New avenues for phage-display library to produce a Cryptococcus-specific anti-idiotypic antibody of HM-1 killer toxin.
Rahman MM; Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
J Mol Recognit; 2011; 24(4):631-41. PubMed ID: 21584874
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
[TBL] [Abstract][Full Text] [Related]
11. Recombinant single-chain anti-idiotypic antibody: an effective fungal beta-1,3-glucan synthase inhibitor.
Selvakumar D; Karim N; Miyamoto M; Furuichi Y; Komiyama T
Biol Pharm Bull; 2006 Sep; 29(9):1848-53. PubMed ID: 16946497
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.
Conti G; Magliani W; Conti S; Nencioni L; Sgarbanti R; Palamara AT; Polonelli L
Antimicrob Agents Chemother; 2008 Dec; 52(12):4331-7. PubMed ID: 18824612
[TBL] [Abstract][Full Text] [Related]
13. From yeast killer toxins to antibiobodies and beyond.
Magliani W; Conti S; Travassos LR; Polonelli L
FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
[TBL] [Abstract][Full Text] [Related]
14. Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs.
Magliani W; Conti S; Ciociola T; Giovati L; Zanello PP; Pertinhez T; Spisni A; Polonelli L
Future Med Chem; 2011 Jul; 3(9):1209-31. PubMed ID: 21806382
[TBL] [Abstract][Full Text] [Related]
15. From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy.
Polonelli L; Magliani W; Ciociola T; Giovati L; Conti S
Antonie Van Leeuwenhoek; 2011 Jan; 99(1):35-41. PubMed ID: 20714805
[TBL] [Abstract][Full Text] [Related]
16. A synthetic peptide as a novel anticryptococcal agent.
Cenci E; Bistoni F; Mencacci A; Perito S; Magliani W; Conti S; Polonelli L; Vecchiarelli A
Cell Microbiol; 2004 Oct; 6(10):953-61. PubMed ID: 15339270
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin.
Selvakumar D; Zhang QZ; Miyamoto M; Furuichi Y; Komiyama T
J Biochem; 2006 Mar; 139(3):399-406. PubMed ID: 16567405
[TBL] [Abstract][Full Text] [Related]
18. Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.
Polonelli L; Beninati C; Teti G; Felici F; Ciociola T; Giovati L; Sperindè M; Lo Passo C; Pernice I; Domina M; Arigò M; Papasergi S; Mancuso G; Conti S; Magliani W
PLoS One; 2014; 9(8):e105727. PubMed ID: 25162681
[TBL] [Abstract][Full Text] [Related]
19. [Construction and screening of human anti-idiotypic single chain antibodies of nasopharyngeal carcinoma].
He XJ; Li GC; Zhu JG; Li YH; Zhou GH
Ai Zheng; 2004 Feb; 23(2):124-9. PubMed ID: 14960228
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.
Polonelli L; Magliani W; Conti S; Bracci L; Lozzi L; Neri P; Adriani D; De Bernardis F; Cassone A
Infect Immun; 2003 Nov; 71(11):6205-12. PubMed ID: 14573638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
